Wire Stories

AM Best Affirms Credit Ratings of Central Reinsurance Corporation

HONG KONG--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of…

6 years ago

AM Best Affirms Credit Ratings of Thaire Life Assurance Public Company Limited

SINGAPORE--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of “a-”…

6 years ago

Global Dental Rapid Prototyping Systems Market to Surpass US$ 7,243.7 Million by 2027, Says Coherent Market Insights (CMI)

SEATTLE--(BUSINESS WIRE)--#DentalPrototyping--According to Coherent Market Insights, the global dental rapid prototyping systems market is estimated to be valued at US$…

6 years ago

Kyowa Kirin Receives Positive CHMP Opinion for the Expanded Use of CRYSVITA® (burosumab) to Include Older Adolescents and Adults for the Treatment of X-Linked Hypophosphataemia (XLH)

XLH is a rare, life-long genetic disease that causes abnormalities in the bones, muscles and joints1,2,3 TOKYO--(BUSINESS WIRE)--Kyowa Kirin Co.,…

6 years ago

Indonesian Telecoms Industry Report 2020-2025 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Indonesia Telecoms Industry Report 2020-2025" report has been added to ResearchAndMarkets.com's offering. This report provides analyses of revenue…

6 years ago

S&P reaffirmed Guotai Junan International’s BBB+ Long-term Issuer Rating

HONG KONG--(BUSINESS WIRE)--Guotai Junan International Holdings Limited (“Guotai Junan International”, the “Company”, stock code:1788) is pleased to announce that Standard…

6 years ago

CSOP CSI 300 Index Daily (2X) Leveraged Product (ticker:7233.HK) and CSOP CSI 300 Index Daily (-1X) Inverse Product (ticker:7333.HK) to List on the HKEX

HONG KONG--(BUSINESS WIRE)--Hong Kong’s largest leveraged and inverse products (L&I products) issuer1, CSOP Asset Management Limited (“CSOP”) is proud to…

6 years ago

EpimAb Biotherapeutics Strengthens Scientific Advisory Board with Addition of Professor Mark Smyth

SHANGHAI, China--(BUSINESS WIRE)--EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the appointment of Professor Mark…

6 years ago

Likee, the Biggest Rival of TikTok, Partners with Believe Digital Bringing a Library of Millions of Songs to Users

SINGAPORE--(BUSINESS WIRE)--Users of Likee – the wildly popular short video app – have even more to sing and dance with…

6 years ago

Aroa Biosurgery Commences Trading on the ASX

HIGHLIGHTS Aroa lists on the ASX today after raising $45m at $0.75/share with an indicative market capitalisation of A$225m under…

6 years ago